Premium
NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42,17 | 196,58 | Sale to Issuer | 4,66 | 33,11k | -0,13% |
| 2026-03-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -2,56k | 11,37k | Vente | 4,44 | 33,11k | -7,18% |
| 2026-03-31 | Mr. Steven MertensCTO | -151,00 | 703,96 | Sale to Issuer | 4,66 | 16,88k | -0,89% |
| 2026-03-31 | Mr. David A. RosaPresident, CEO & Director | -409,67 | 1,91k | Sale to Issuer | 4,66 | 124,73k | -0,33% |
| 2026-03-12 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -152,83 | 733,60 | Vente | 4,80 | 35,71k | -0,43% |
| 2026-03-10 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -2,29k | 10,98k | Vente | 4,80 | 33,64k | -6,37% |
| 2026-03-01 | Mr. David J. WambekeChief Business Officer | 166,67k | 670,40k | Achat | 4,02 | 166,67k | - |
| 2026-02-18 | Mr. Steven MertensCTO | -1,23k | 5,02k | Sale to Issuer | 4,08 | 16,51k | -6,93% |
| 2026-02-18 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -302,00 | 1,23k | Sale to Issuer | 4,08 | 35,92k | -0,83% |
| 2026-02-18 | Mr. David A. RosaPresident, CEO & Director | -11,89k | 48,50k | Sale to Issuer | 4,08 | 124,19k | -8,74% |
| 2025-12-31 | Mr. Steven MertensCTO | -151,00 | 686,75 | Sale to Issuer | 4,55 | 12,98k | -1,15% |
| 2025-12-31 | Mr. David A. RosaPresident, CEO & Director | -409,67 | 1,86k | Sale to Issuer | 4,55 | 107,48k | -0,38% |
| 2025-12-31 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42,17 | 191,77 | Sale to Issuer | 4,55 | 35,04k | -0,12% |
| 2025-09-30 | Mr. Steven MertensCTO | -151,00 | 805,07 | Sale to Issuer | 5,33 | 12,61k | -1,18% |
| 2025-09-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42,17 | 224,82 | Sale to Issuer | 5,33 | 35,08k | -0,12% |
| 2025-09-30 | Mr. David A. RosaPresident, CEO & Director | -409,67 | 2,18k | Sale to Issuer | 5,33 | 107,89k | -0,38% |
| 2025-09-05 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -5,00k | 22,20k | Vente | 4,44 | 34,98k | -12,51% |
| 2025-06-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42,17 | 171,53 | Sale to Issuer | 4,07 | 39,83k | -0,11% |
| 2025-06-30 | Mr. Steven MertensCTO | -151,00 | 614,27 | Sale to Issuer | 4,07 | 12,24k | -1,22% |
| 2025-06-30 | Mr. David A. RosaPresident, CEO & Director | -409,67 | 1,67k | Sale to Issuer | 4,07 | 106,39k | -0,38% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
